In this issue of Px Wire, our centerspread graphic looks at the sum total of the new targets and guidelines and gives our “take” on whether the current context is on target.
The New Context for HIV Prevention: Is the world on target?
A Pipeline of Promise: Global Health Research and Product Development Process
Global Health Technologies presents an infographic overview of the many steps it takes to bring a product to market.
A Pipeline of Promise: Global Health Research and Product Development Process
Global Health Technologies presents an infographic overview of the many steps it takes to bring a product to market.
Planned, Ongoing and Completed PrEP Evaluation studies (July 2015)
This graphic, appearing in AVAC Report 2014/15: HIV Prevention on the Line, shows the planned, ongoing and completed PrEP evaluation studies as of July 2015.
Vaccine Research: An overview
This graphic shows the big picture of AIDS vaccine concepts and clinical trials in process and on the horizon. It is an internationally simplified representation of a complex field. Some approaches are not listed, and related arenas like and cure research are omitted.
Additional Vaccine Approaches
A range of vaccine approaches are being tested in early phase clinical trials. This table provides highlights of this area of vaccine research.
Neutralizing Antibodies
This graphic explains on how neutralizing antibodies work, provides research background and gives an advocates’ checklist for what to look for going forward.
Vaccine Research Developing Programs
This graphic provides a state of the field on vaccine research development programs, giving details on the Pox-Protein Public-Private Partnership trials testing canarypox-protein based vaccine candidates and the Jannssen development program of Ad26 vector + Mosaic immunogen vaccine strategy.
Selected Guide to Pipeline of Antibodies, Long-Acting ARVs and Vaccines
This graphic provides a quick primer on passive immunization with HIV-specific antibodies, long-acting antiretroviral injectables, and preventive vaccines, including a new, informative table reviewing the pipelines in research and development for all three research avenues.
What’s Next for the Pox-Protein Public-Private Partnership (P5)?
This timeline, appearing in AVAC Report 2014/2015: HIV Prevention on the Line, shows the progress and future of the P5.